WHO Classifies Two Major Food Additives PFAS as Carcinogenic to Humans, Underlines Risk of Dietary Exposure
The International Agency for Research on Cancer (IARC), the cancer agency of the World Health Organization (WHO), has evaluated the carcinogenicity of two types of per- and polyfluoralkyl substances—perfluorooctanoic acid (PFOA) and perfluorooctanesulfonic acid (PFOS)—and classified them as “carcinogenic to humans” (Group 1) and “possibly carcinogenic to humans,” (Group 2B) respectively.
PFAS are often called “forever chemicals” due to their indefinite persistence in the human body and the environment, as they take a very long time to degrade and build up over time. In recent years, their pervasiveness in drinking water has been noted by experts in the UK, the U.S., and globally, and the body of evidence regarding their harms to human health has grown. PFAS, including PFOS and PFOA, have been used in non-stick and stain-resistant consumer products, such as cookware, as well as in food packaging. However, some state and national governments are beginning to restrict or ban the use of certain PFAS, and some companies are beginning to voluntarily phase them out from products.
At an IARC meeting that took place November 7–14, 2023 in Lyon, France, a working group of 30 international experts spanning 11 countries thoroughly reviewed published literature on PFOA and PFOS, resulting in the classification of PFOA as “carcinogenic to humans” (Group 1) and PFOS as “possibly carcinogenic to humans” (Group 2B).
PFOA is carcinogenic to humans on the basis of sufficient evidence for cancer in experimental animals and strong mechanistic evidence (for epigenetic alterations and immunosuppression) in exposed humans. There was also limited evidence for cancer in humans (renal cell carcinoma and testicular cancer) and strong mechanistic evidence in human primary cells and experimental systems (for epigenetic alterations and immunosuppression, as well as several other key characteristics of carcinogens).
PFOS is possibly carcinogenic to humans on the basis of strong mechanistic evidence across test systems, including in exposed humans (for epigenetic alterations and immunosuppression, as well as several other key characteristics of carcinogens). There was also limited evidence for cancer in experimental animals and inadequate evidence regarding cancer in humans.
IARC noted that the general population that does not work with PFOS and PFOA in industrial contexts are mainly exposed to the chemicals by consuming food and drinking water, and acknowledged that PFOA and PFOS are ubiquitously present in the environment, even in the most remote areas.
2026-09-06
Trade Alert
Delivering the latest product trends and industry news straight to your inbox.
(We'll never share your email address with a third-party.)
Related News
-
UK AGC Plans to Close PFAS Plant as Pressure on Europe’s Fluorochemicals Sector Intensifies
-
Critical PFAS Insights Revealed in New Industry Whitepaper at Chemspec Europe
-
Lubrizol Announces Elimination of PFAS from Its Peptide Synthesis Process
-
France Bans PFAS in Cosmetics and Consumer Textiles
-
New REACH measures restrict PFAS subclass PFHxA
-
FAO/WHO Expert Committee Advances Foodborne Virus Research for Codex Guidance Enhancement
-
WHO Clarifies That One Dose Of Hpv Vaccine Is Enough Jiffy Biologicals Plunges
-
Ukraine Strikes Russia’s Ryazan Refinery Again, Setting 17-Million-Tonne Facility Ablaze
-
Wanhua Chemical Raises Southeast Asia MDI and TDI Offers by $200 per Tonne
-
European Diesel Crack Spread Hits Record $74.66 per Barrel as Global Refinery Outages Mount
Recommend Reading
-
Global Chemical Giants Accelerate Plant Closures and Layoffs as Industry Enters Structural Capacity Rationalization
-
Ukraine Strikes Russia’s Perm Refinery Again, Forcing Crude Unit Offline at 260,000-BPD Facility
-
A White Storm Sweeps Through “Golden October”: China’s Titanium Dioxide Giants Join Forces in a Battle for SurvivalA White Storm Sweeps Through “Golden October”: China’s Titanium Dioxide Giants Join Forces in a Battle for Survival
-
J&J to Spin Off Orthopedics Business, Raises 2025 Forecast
-
Aspen Secures Approval to Market Lilly’s Mounjaro for Weight Loss in South Africa
-
This week, the soda ash market in China showed a weak downward trend
-
October Adipic Acid Market Weakens and Falls
-
This week, the 180CST fuel oil market in China remained largely stable
-
Cost Decline, Weak Demand—Oxynol Prices Fluctuate and Fall This Week
-
Premium Global Chemical Sourcing Requests (15-19 Sep 2025)